We are live on ! Find out more
Skandinaviska Enskilda Banken (SEB)

Skandinaviska Enskilda Banken (SEB) Portfolio holdings

AUM $2.66B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
-0.81%
1 Year Est. Return
+26.2%
3 Year Est. Return
+111.17%
5 Year Est. Return
+154.66%
10 Year Est. Return
+614.64%
AUM
$10.4B
AUM Growth
-$1.25B
Cap. Flow
-$1.2B
Cap. Flow %
-11.58%
Top 10 Hldgs %
26.01%
Holding
742
New
32
Increased
158
Reduced
480
Closed
40

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$149M
2
KMB icon
Kimberly-Clark
KMB
+$142M
3
CA
CA, Inc.
CA
+$110M
4
T icon
AT&T
T
+$76.8M
5
CM icon
Canadian Imperial Bank of Commerce
CM
+$64.9M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$289M
2
BMY icon
Bristol-Myers Squibb
BMY
+$91.3M
3
FL
Foot Locker
FL
+$89.4M
4
INTC icon
Intel
INTC
+$89.2M
5
JNJ icon
Johnson & Johnson
JNJ
+$78.9M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Healthcare 18.3%
3 Financials 15.97%
4 Consumer Discretionary 14.12%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
26
United Therapeutics
UTHR
$21.9B
$94.5M 0.91%
840,623
-202,700
-19% -$25.8M
KLAC icon
27
KLA
KLAC
$272B
$91.8M 0.89%
8,424,470
+42,670
+0.5% +$475K
MGA icon
28
Magna International
MGA
$18.6B
$90.1M 0.87%
1,598,474
+146,993
+10% +$8.21M
META icon
29
Meta Platforms (Facebook)
META
$1.47T
$88.6M 0.85%
554,707
-125,553
-18% -$22.5M
ABBV icon
30
AbbVie
ABBV
$440B
$87.1M 0.84%
920,065
-109,787
-11% -$12.1M
MRK icon
31
Merck
MRK
$328B
$85.2M 0.82%
1,638,863
+914,032
+126% +$49.4M
PEP icon
32
PepsiCo
PEP
$189B
$83.7M 0.81%
767,281
-71,899
-9% -$8.18M
AVY icon
33
Avery Dennison
AVY
$13.7B
$81.6M 0.79%
768,132
-308,260
-29% -$35.7M
VZ icon
34
Verizon
VZ
$195B
$81.2M 0.78%
1,697,132
-132,625
-7% -$6.67M
AFL icon
35
Aflac
AFL
$60.5B
$72.1M 0.69%
1,646,570
-1,246
-0.1% -$55.1K
BIIB icon
36
Biogen
BIIB
$30.9B
$71.4M 0.69%
260,792
-3,307
-1% -$1.03M
GILD icon
37
Gilead Sciences
GILD
$168B
$71M 0.68%
942,262
-3,634,807
-79% -$289M
AMZN icon
38
Amazon
AMZN
$2.88T
$70.2M 0.68%
969,880
-467,760
-33% -$33.4M
KR icon
39
Kroger
KR
$34.3B
$70.2M 0.68%
2,930,744
+1,302,253
+80% +$35.4M
TSN icon
40
Tyson Foods
TSN
$19.6B
$66.5M 0.64%
908,971
+10,176
+1% +$777K
AMGN icon
41
Amgen
AMGN
$225B
$66.3M 0.64%
389,144
-247,789
-39% -$45.5M
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.19T
$63.6M 0.61%
1,232,080
-295,980
-19% -$16.3M
TXN icon
43
Texas Instruments
TXN
$253B
$62.8M 0.61%
604,778
-493,518
-45% -$53.4M
APO icon
44
Apollo Global Management
APO
$81.9B
$60.3M 0.58%
2,036,684
-37,400
-2% -$1.26M
LLY icon
45
Eli Lilly
LLY
$1.09T
$59.7M 0.58%
772,222
-56,071
-7% -$4.51M
AEO icon
46
American Eagle Outfitters
AEO
$2.72B
$57.7M 0.56%
2,896,500
+1,020,400
+54% +$19.1M
GOOGL icon
47
Alphabet (Google) Class A
GOOGL
$4.2T
$56.7M 0.55%
1,092,820
-420,340
-28% -$23.3M
BEN icon
48
Franklin Resources
BEN
$17.1B
$56.6M 0.55%
1,631,968
+940,018
+136% +$38.2M
PEG icon
49
Public Service Enterprise Group
PEG
$37.8B
$56.5M 0.54%
1,125,200
-228,967
-17% -$11.2M
PG icon
50
Procter & Gamble
PG
$335B
$56M 0.54%
706,535
+62,802
+10% +$5.24M

Similar funds

Skandinaviska Enskilda Banken (SEB)'s Q1 2018 Portfolio in Review

As of Q1 2018, Skandinaviska Enskilda Banken (SEB) held 742 positions worth $10.4B, down 11% from $11.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Skandinaviska Enskilda Banken (SEB) withdrew a net $1.2B in Q1 2018, closing 40 positions and reducing 480 holdings. Its most notable exit was Global Cord Blood Corporation, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Skandinaviska Enskilda Banken (SEB) opened a new position in Xerox worth $15.9M.

  • Skandinaviska Enskilda Banken (SEB)'s largest Q1 2018 buy was Xerox: 550,760 shares worth $15.9M.
  • Skandinaviska Enskilda Banken (SEB) added most to Pfizer in Q1 2018, an estimated $149M increase.
  • Skandinaviska Enskilda Banken (SEB)'s biggest Q1 2018 reduction was Gilead Sciences, cutting an estimated $289M.
  • Skandinaviska Enskilda Banken (SEB) fully exited Global Cord Blood Corporation in Q1 2018, selling an estimated $29.2M.
  • Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 26% of its $10.4B portfolio in Q1 2018.
  • Skandinaviska Enskilda Banken (SEB) opened 32 new positions and closed 40 in Q1 2018.
  • Skandinaviska Enskilda Banken (SEB)'s portfolio value fell 11% quarter-over-quarter to $10.4B.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2018, filed 30 Apr 2018.